Welcome to our dedicated page for Wellbeing Digital Sciences news (Ticker: KONEF), a resource for investors and traders seeking the latest updates and insights on Wellbeing Digital Sciences stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Wellbeing Digital Sciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Wellbeing Digital Sciences's position in the market.
Wellbeing Digital Sciences (OTC: KONEF) has announced its intention to request a public meeting with the FDA regarding new guidelines for probiotics, following the FDA's recent release of draft guidance on New Dietary Ingredients. CEO Najla Guthrie emphasizes the need for a focused discussion to address unresolved issues critical to the probiotic industry. The meeting aims to further enhance communication between the industry and FDA, ensuring comprehensive understanding of complex topics related to probiotics, including NDI regulations.
Wellbeing Digital Sciences Inc. (NEO: MEDI, OTC: KONEF) announced Dr. Corey Hilmas' participation at the 2022 IPA World Congress and Probiota Americas event in Washington D.C. from June 1-3, 2022. Dr. Hilmas, a member of the Medical Advisory Board and Chief Regulatory Officer of KGK Science, will join a panel to discuss vital issues in the probiotics sector, including labelling and safety. The event, organized by William Reed Ltd., features leading experts and offers networking opportunities. Additionally, the company granted 1,260,000 restricted share units as part of its RSU plan.
Wellbeing Digital Sciences Inc. (OTC: KONEF) announces the resignation of its Chief Financial Officer, Joseph Ramelli, effective immediately. The Board expresses gratitude for his contributions since his appointment in late 2021. A new CFO is expected to be announced soon. Wellbeing is dedicated to evidence-based mental healthcare, including innovative clinical solutions like psychedelic medicine and digital therapeutics, supported by a network of North American clinics and a contract research organization.
Wellbeing Digital Sciences Inc. (OTC: KONEF) has announced its role as a founding sponsor of the Women in Psychedelics Network (WIP). Led by CEO Najla Guthrie, WIP aims to unite women in the psychedelic industry for education and support. Guthrie emphasizes mentoring and advocacy for psychedelic medicine in mental health. Additionally, the company issued 5,000,000 common shares to an agent for strategic partnerships at $0.25 each and granted 210,000 restricted share units to an arm's length consultant.
Wellbeing Digital Sciences Inc. (NEO: MEDI, OTC: KONEF) announces the appointment of Dr. Michael Ho as the new Medical Director of the MindScape Ketamine & Infusion Therapy Clinic in Houston, Texas, effective May 2, 2022. This follows the retirement of the clinic's founder, Dr. Quang Henderson. Since its acquisition on April 21, 2021, MindScape has completed over 600 low-dose ketamine infusions, marking a significant milestone. The company is also exploring additional mental health services and implementing a new marketing strategy to expand its local patient base.
Wellbeing Digital Sciences Inc. (OTC: KONEF) announced that its subsidiary, IRP Health, has been certified by Veterans Affairs Canada for its Reactivation program. The Chronic Pain Centre of Excellence for Canadian veterans has integrated IRP Health’s four clinics into its national network. This initiative aims to advance chronic pain research and support veterans' well-being through a comprehensive 12-week therapy program that combines various disciplines. The program is designed to alleviate chronic pain and enhance everyday functioning for veterans.
Wellbeing Digital Sciences has signed a memorandum of understanding (MOU) with Pathway Health Corp to facilitate the acquisition of certain Canadian assets. This transaction, expected to conclude by June 30, 2022, involves a two-stage closing process. Pathway aims to license Wellbeing's pain management program and intellectual property for intravenous ketamine services. The MOU outlines a franchise model and includes crucial elements like due diligence and board approvals. Management expressed excitement about enhancing mental health services for military veterans and first responders.
Wellbeing Digital Sciences Inc. (OTC: KONEF) announces significant developments from its wholly-owned subsidiary, KGK Science Inc., in Q1 2022. The CRO secured six new contracts and completed two clinical study reports, including a COVID-19 study. Regulatory approvals were obtained for two trials focusing on mood and immune health. KGK's team also performed claims reviews for dietary supplements and prepared for presentations at notable industry events. CEO Najla Guthrie praised KGK's progress as essential to Wellbeing's strategy in innovative mental health solutions.
Wellbeing Digital Sciences Inc. has announced a revitalized mission to enhance mental health services led by newly appointed CEO Najla Guthrie. The strategy focuses on expanding psychedelic treatment services and contemporary mental health clinics across North America. With an emphasis on clinical research and the integration of digital therapeutics, Wellbeing aims to address significant barriers in mental healthcare access, thus improving patient outcomes. The comprehensive plan aspires to establish Wellbeing as a leading healthcare provider in the mental health sector.
Wellbeing Digital Sciences Inc. (OTC: KONEF) announced the appointment of Najla Guthrie as CEO effective March 31, 2022. Guthrie, previously President of KGK Science, aims to enhance the company's strategic direction in mental health treatments. Recent achievements include KGK's collaboration with Lophos Pharmaceuticals for a peyote study and IRP Health's approval for a PTSD treatment plan by Veterans Affairs Canada. Wellbeing is also progressing towards a U.S. stock exchange listing, with audits for fiscal years 2020 and 2021 underway.
FAQ
What is the current stock price of Wellbeing Digital Sciences (KONEF)?
What is the market cap of Wellbeing Digital Sciences (KONEF)?
